Portal de Periódicos da CAPES

C‐reactive protein levels as a direct indicator of interleukin‐6 levels in humans in vivo

1992; Wiley; Volume: 35; Issue: 8 Linguagem: Inglês

10.1002/art.1780350824

1529-0131

Régis Bataille, Bernard Klein,

Inflammasome and immune disorders

Arthritis & RheumatismVolume 35, Issue 8 p. 982-983 LetterFree to Read C-reactive protein levels as a direct indicator of interleukin-6 levels in humans in vivo RÉGis Bataille MD, Ph.D, RÉGis Bataille MD, Ph.D Institut de Biologie, Hǒtel-Dieu, Nantes, FranceSearch for more papers by this authorBernard Klein Ph.D, Bernard Klein Ph.D Institut de Biologie, Hǒtel-Dieu, Nantes, FranceSearch for more papers by this author RÉGis Bataille MD, Ph.D, RÉGis Bataille MD, Ph.D Institut de Biologie, Hǒtel-Dieu, Nantes, FranceSearch for more papers by this authorBernard Klein Ph.D, Bernard Klein Ph.D Institut de Biologie, Hǒtel-Dieu, Nantes, FranceSearch for more papers by this author First published: August 1992 https://doi.org/10.1002/art.1780350824Citations: 105AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat No abstract is available for this article. References 1 Kushner I: C-reactive protein in rheumatology (editorial). Arthritis Rheum 34: 1065–1068, 1991 2 Hirano T, Akira S, Taga T, Kishimoto T: Biological and clinical aspects of interleukin-6. Immunol Today 11: 443–449, 1990 3 Castell JV, Gomez-Lechon MJ, David M, Fabra R, Trullenque R, Heinrich PC: Acute phase response of human hepatocytes: regulation of acute phase protein synthesis by interleukin-6. Hepatology 12: 1179–1186, 1990 4 Kawano M, Hirano T, Matsuda T, Taga T, Horii Y, Iwato K, Asaoku H, Tang B, Tanabe O, Tanaka H, Kuramoto A, Kishimoto T: Autocrine generation and requirement of BSF-2/IL-6 for human multiple myelomas. Nature 332: 83–85, 1988 5 Klein B, Zhang XG, Jourdan M, Content J, Houssiau F, Aarden L, Piechaczyk M, Bataille R: Paracrine rather than autocrine regulation of myeloma-cell growth and differentiation by interleukin-6. Blood 73: 517–526, 1989 6 Miki S, Iwano M, Miki Y, Yamamoto M, Tang B, Yokokawa K, Sonoda T, Hirano T, Kishimoto T: Interleukin-6 (IL-6) functions as an in vitro autocrine growth factor in renal cell carcinomas. FEBS Lett 250: 607–610, 1989 7 Van der Schoot CE, Jansen P, Poorter M, Wester MR, van dem Borne AEG, Aarden LA, van Oers RHJ: Interleukin-6 and interleukin-1 production in acute leukemia with monocytoid differentiation. Blood 74: 2081–2087, 1989 8 Klein B, Wijdenes J, Zhang XG, Jourdan M, Boiron JM, Brochier J, Liautard J, Merlin M, Clement C, Morel-Fournier B, Lu ZY, Mannoni P, Sany J, Bataille R: Murine anti-interleukin-6 monoclonal antibody therapy for a patient with plasma cell leukemia. Blood 78: 1198–1204, 1991 9 Racadot E, Clement C, Wendling D, Lioure B, Audhuy B, Lang JM, Wijdenes J: Therapeutic use of anti-interleukin-6 (IL-6) monoclonal antibodies, IL-6: Physiopathology and Clinical Potentials, Montreux Palace Meeting. Montreux, Switzerland, October 21–23, 1991 10 Jourdan M, Bataille R, Seguin J, Zhang XG, Chaptal PA, Klein B: Constitutive production of interleukin-6 and immunologic features in cardiac myxomas. Arthritis Rheum 33: 398–402, 1990 11 Cush JJ, Lipsky PE, Postlethwaite AE, Schrohenloher RE, Saway A, Koopman WJ: Correlation of serologic indicators of inflammation with effectiveness of nonsteroidal antiinflammatory drug therapy in rheumatoid arthritis. Arthritis Rheum 33: 19–28, 1990 12 Bataille R, Klein B: The bone resorbing activity of IL-6. J Bone Miner Res 9: 1144–1145, 1991 Citing Literature Volume35, Issue8August 1992Pages 982-983 ReferencesRelatedInformation